Related Experiment Video
Updated: Aug 12, 2026
10:16
Autoradiography as a Simple and Powerful Method for Visualization and Characterization of Pharmacological Targets
Published on: March 12, 2019
[Kinetics of hepatotropic radiopharmaceuticals]
Meditsinskaia Radiologiia
|September 1, 1985
Summary
This study compared radiopharmaceuticals for jaundice diagnosis. Iminodiacetic acid derivatives showed better blood clearance and liver transit than labeled stains, with Soviet agents matching foreign standards.
Area of Science:
- Nuclear medicine
- Radiopharmaceutical research
- Medical diagnostics
Background:
- Jaundice diagnosis relies on imaging agents.
- Understanding radiopharmaceutical biodistribution is crucial for effective diagnostics.
- Comparing different classes of agents can optimize clinical use.
Purpose of the Study:
- To investigate the biological distribution of 131I labeled stains and 99mTc labeled iminodiacetic acid derivatives.
- To compare the pharmacokinetic behavior of these agents in patients with jaundice.
- To evaluate the efficacy of Soviet-developed radiopharmaceuticals against international standards.
Main Methods:
- Biological distribution study in 153 patients (98 with jaundice).
- Comparison of 131I labeled stains and 99mTc labeled iminodiacetic acid derivatives.
- Analysis of blood clearance, hepatocyte transit, and renal excretion rates.
Main Results:
- Significant differences in biodistribution based on chemical structure were observed.
- Iminodiacetic acid derivatives exhibited 1.5-2 times higher blood clearance than labeled stains.
- 99mTc-MESIDA, 99mTc-DIDA, and 99mTc-TIDA showed the highest hepatocyte transit rates.
- Renal excretion varied with molecular structure; retarded blood clearance reduced liver excretion and increased urinary excretion.
- Soviet radiopharmaceuticals 99mTc-MESIDA and 99mTc-BUTILIDA demonstrated comparable pharmacokinetic characteristics and quality to leading foreign analogs.
Conclusions:
- Chemical structure critically influences radiopharmaceutical biodistribution and excretion.
- Iminodiacetic acid derivatives represent an improvement over labeled stains for jaundice imaging.
- Soviet radiopharmaceuticals are competitive with international standards in terms of quality and pharmacokinetics.
Related Concept Videos
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
01:17Hepatic Drug Excretion: Enterohepatic Cycling
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion, mediated...
A recent model describes pravastatin's hepatobiliary excretion, mediated...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...